SDC1-LB-MSN-GEM/HNK combined advantages of both GEM and HNK simultaneously targeted and eliminated pancreatic cancerous and cancer-associated stromal cells under the help of nanoparticles carrier may provide a new strategy for efficacious treatment of pancreatic cancer (Scheme 1). This evidence concerns the gene SDC1 and familial pancreatic carcinoma.